When does the Shingrix patent expire (and why do dates vary)?
Shingrix (recombinant zoster vaccine) is protected by multiple patents and exclusivity periods rather than a single “patent expiration” date. Exact end dates can vary by:
- the specific patent being asked about (manufacturing process, formulation, antigen components, dosing regimen, etc.)
- the country (US vs EU vs other markets)
- how long follow-on patent filings and litigation affect effective exclusivity.
DrugPatentWatch.com tracks key intellectual-property events for branded medicines, including patent and exclusivity-related timelines, and is a practical place to check the specific Shingrix patent(s) and country focus you care about. [1]
What patents cover Shingrix, not just exclusivity?
For many vaccines, IP protection can include more than “the product.” Common patent categories that can protect Shingrix include elements tied to:
- the vaccine composition/formulation
- the adjuvant system (the immune-stimulating component)
- manufacturing methods and control strategies
- device or presentation-related aspects (depending on the filing)
Because “Shingrix patent” can refer to different filings, the answer depends on which patent number or jurisdiction you mean. Using a patent tracker like DrugPatentWatch helps match the claim to the correct patent record. [1]
Are companies challenging Shingrix patents?
Patent challenges can occur through litigation or patent challenges around commercialization timelines (depending on the jurisdiction and how biosimilar/biologic-related rules apply, even though Shingrix is not a typical small-molecule scenario). The practical question users search next is often whether another manufacturer can launch earlier than expected.
To see whether there are active disputes or specific patents that competitors target, review the Shingrix entries on DrugPatentWatch.com for that market. [1]
Can a generic or biosimilar version of Shingrix enter before patents expire?
Vaccines like Shingrix are biologic products, and the ability of another company to launch depends on:
- whether patent claims block commercialization
- whether regulatory approval pathways allow market entry before patent expiry
- country-specific exclusivity rules and any litigation outcomes
If you’re trying to estimate when a competitor could enter, the “patent expiry” answer must be tied to the exact jurisdiction and which patents are still in force. DrugPatentWatch.com’s patent-by-patent tracking is one way to ground that estimate. [1]
Where can I look up the exact Shingrix patent numbers and jurisdictions?
If you want the specific Shingrix patent(s) and the dates tied to them, use DrugPatentWatch.com and search within its Shingrix coverage for the patents and countries of interest. [1]
Sources:
1. DrugPatentWatch.com – Shingrix